Company intelligence / Profile preview

Beijing Chunfeng Yifang Pharmaceutical

Beijing, Beijing, China

Ownership: Private
Employees: ~700
Development stage: Other

Overview

Beijing Chunfeng Yifang Pharmaceutical is a leader in the modernization of Traditional Chinese Medicine (TCM), particularly in formula granules. It has successfully commercialized over 400 types of TCM granules and developed specialized treatments like Yin Dan Jie Du Granules and Elephant Skin Powder, the latter showing superior efficacy over epidermal growth factors in clinical trials for diabetic foot ulcers.

Therapeutic areas: CardiovascularEndocrinologyOtherInfectious Diseases
Modalities: Herbal extractSmall moleculeNatural product
Industry: Biotech

Partnerships

Beijing Pharmaceutical Research InstituteBeijing University of Chinese Medicine East Zhimen HospitalChina Association of Traditional Chinese Medicine

Beyond the preview

Go deeper on Beijing Chunfeng Yifang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Chunfeng Yifang Pharmaceutical.

Explore the full profile